Financial Summary -
Novartis Pharma Services Romania Srl
Unique identification code:27813234
Registration number:J2010012258409
Nace:4646
Sales - Ron
201.495.277
Net Profit - Ron
5.800.841
Employees
178
Open Account
Company Novartis Pharma Services Romania Srl with Fiscal Code 27813234
recorded a turnover of 2024 of
201.495.277,
with a net profit of
5.800.841
and having an average number of employees of
178.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Novartis Pharma Services Romania Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
100.823.097
105.102.319
122.747.821
-
143.911.355
171.341.812
177.750.633
202.182.125
238.324.384
201.495.277
Total Income - EUR
101.432.615
105.164.863
122.897.822
-
143.944.194
172.891.573
177.767.213
202.187.485
238.339.760
201.508.873
Total Expenses - EUR
96.438.723
100.821.884
119.388.965
-
137.402.273
169.497.803
168.974.309
194.132.775
229.291.915
192.720.190
Gross Profit/Loss - EUR
4.993.892
4.342.979
3.508.857
-
6.541.921
3.393.770
8.792.904
8.054.709
9.047.845
8.788.683
Net Profit/Loss - EUR
3.988.062
3.574.970
1.637.834
-
4.446.130
1.306.427
7.014.071
6.148.187
6.257.952
5.800.841
Employees
138
128
154
-
176
191
197
187
192
178
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -15.0%, from 238.324.384 euro in the year 2023, to 201.495.277 euro in 2024.
The Net Profit decreased by -422.137 euro, from 6.257.952 euro in 2023, to 5.800.841 in the last year.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Novartis Pharma Services Romania Srl - CUI 27813234
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
1.677.090
1.386.427
586.090
-
562.061
409.288
1.041.825
846.889
948.971
2.122.320
Current Assets
65.114.334
84.298.745
97.112.177
-
125.990.107
133.832.735
118.348.399
151.506.712
210.371.401
183.962.763
Inventories
17.244.559
31.645.171
32.893.734
-
41.121.179
41.716.628
34.226.942
56.123.851
75.883.100
79.946.252
Receivables
45.905.021
52.637.036
64.074.578
-
81.468.901
91.169.592
84.037.212
95.314.155
111.277.470
103.915.768
Cash
1.964.754
16.538
143.864
-
3.400.026
946.515
84.244
68.706
23.210.830
100.744
Shareholders Funds
7.378.309
10.878.031
12.331.790
-
22.364.997
23.247.437
29.745.973
35.986.447
42.135.272
47.938.455
Social Capital
674.916
668.032
656.728
-
632.191
620.206
606.453
608.334
606.489
603.100
Debts
59.609.683
74.842.350
81.391.600
-
102.492.544
111.136.268
89.719.027
116.390.287
168.988.004
138.219.499
Income in Advance
0
0
0
-
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
183.962.763 euro in 2024 which includes Inventories of
79.946.252 euro, Receivables of
103.915.768 euro and cash availability of
100.744 euro.
The company's Equity was valued at
47.938.455 euro, while total Liabilities amounted to
138.219.499 euro.
Equity increased by 6.038.666 euro, from 42.135.272 euro in 2023, to 47.938.455 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Novartis Pharma Services Romania Srl